EGF Theramed Health Corp.
TMED
CNSX
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -661.58% | -1,186.43% | -1,065.21% | -27.66% | -22.36% |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 3,650.18% | 4,943.33% | 4,203.06% | 86.02% | 178.22% |
| Change in Net Operating Assets | -76.76% | -61.60% | 364.31% | 230.98% | 155.14% |
| Cash from Operations | -1,905.88% | -269.05% | 124.52% | 125.15% | 97.34% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -80.00% | -100.00% | -100.00% | -100.00% |
| Total Debt Repaid | 100.00% | -- | -- | -- | -1,132.00% |
| Issuance of Common Stock | -- | -- | -- | -100.00% | -100.00% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 440.00% | -204.08% | -118.15% | -115.28% | -111.63% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 66.82% | -258.12% | 1,028.57% | 630.43% | -178.97% |